AIM Total Stockholder Equity vs Total Current Liabilities Analysis
0A4Y Stock | 0.22 0.01 4.35% |
AIM ImmunoTech financial indicator trend analysis is way more than just evaluating AIM ImmunoTech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AIM ImmunoTech is a good investment. Please check the relationship between AIM ImmunoTech Total Stockholder Equity and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.
Total Stockholder Equity vs Total Current Liabilities
Total Stockholder Equity vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AIM ImmunoTech Total Stockholder Equity account and Total Current Liabilities. At this time, the significance of the direction appears to have pay attention.
The correlation between AIM ImmunoTech's Total Stockholder Equity and Total Current Liabilities is -0.79. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of AIM ImmunoTech, assuming nothing else is changed. The correlation between historical values of AIM ImmunoTech's Total Stockholder Equity and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of AIM ImmunoTech are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Stockholder Equity i.e., AIM ImmunoTech's Total Stockholder Equity and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -0.79 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Total Current Liabilities
Total Current Liabilities is an item on AIM ImmunoTech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of AIM ImmunoTech are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from AIM ImmunoTech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AIM ImmunoTech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy AIM Stock please use our How to Invest in AIM ImmunoTech guide.Selling General Administrative is likely to drop to about 8 M in 2024
AIM ImmunoTech fundamental ratios Correlations
Click cells to compare fundamentals
AIM ImmunoTech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AIM ImmunoTech fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.2M | 13.8M | 20.8M | 64.6M | 74.3M | 78.0M | |
Total Current Liabilities | 5.3M | 1.1M | 1.1M | 673K | 605.7K | 575.4K | |
Total Stockholder Equity | 8.7M | 5.2M | 13.4M | 61.3M | 70.5M | 74.0M | |
Retained Earnings | (318.6M) | (327.6M) | (342.0M) | (361.1M) | (325.0M) | (341.2M) | |
Cash | 1.4M | 299K | 1.5M | 38.5M | 44.3M | 46.5M | |
Other Assets | 1.4M | 1.9M | 748K | 1.3M | 1.2M | 1.1M | |
Cash And Short Term Investments | 2.1M | 1.8M | 8.8M | 39.0M | 44.9M | 47.1M | |
Short Term Investments | 695K | 1.5M | 7.3M | 501K | 576.2K | 547.3K | |
Capital Surpluse | 317.4M | 323.7M | 340.2M | 402.5M | 462.9M | 374.0M | |
Total Liab | 5.5M | 8.7M | 7.3M | 3.3M | 3.8M | 6.2M | |
Total Current Assets | 3.8M | 10.4M | 40.3M | 50.2M | 57.7M | 60.6M | |
Intangible Assets | 858K | 912K | 1.2M | 1.5M | 1.7M | 1.2M | |
Common Stock | 1K | 10K | 42K | 48K | 55.2K | 29.0K | |
Property Plant Equipment | 7.8M | 7.3M | 6.7M | 4.2M | 3.8M | 5.9M | |
Other Liab | 1.1M | 57K | 180K | 35K | 31.5K | 29.9K | |
Net Tangible Assets | 4.3M | 11.5M | 59.1M | 54.2M | 62.3M | 65.4M | |
Accounts Payable | 680K | 472K | 383K | 198K | 178.2K | 169.3K | |
Net Receivables | 1.1M | 820K | 1.1M | 1.6M | 1.9M | 1.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.